Resolution of Multifocal Epstein-Barr Virus-Related Smooth Muscle Tumor in a Patient with GATA2 Deficiency Following Hematopoietic Stem Cell Transplantation.
Mark PartaJennifer Cuellar-RodriguezAlexandra F FreemanJuan Gea-BanaclocheSteven M HollandDennis D HicksteinPublished in: Journal of clinical immunology (2016)
We performed allogeneic hematopoietic stem cell transplantation in a patient with GATA2 deficiency and an Epstein-Barr virus (EBV)-related spindle cell tumor involving the liver and possibly bone. He received a matched-related donor transplant with donor peripheral blood stem cells following a myeloablative conditioning regimen. He achieved rapid and high levels of donor engraftment and had complete reversal of the clinical and immunologic phenotype of MonoMAC/GATA2 deficiency and eradication of the EBV tumors after 3 years of follow-up. Thus, allogeneic hematopoietic stem cell transplant results in reconstitution of immunologic function and cure of EBV-associated malignancy in MonoMAC/GATA2 deficiency.
Keyphrases
- epstein barr virus
- diffuse large b cell lymphoma
- allogeneic hematopoietic stem cell transplantation
- hematopoietic stem cell
- transcription factor
- stem cells
- smooth muscle
- peripheral blood
- acute myeloid leukemia
- stem cell transplantation
- replacement therapy
- acute lymphoblastic leukemia
- case report
- single cell
- bone marrow
- mesenchymal stem cells
- smoking cessation
- bone loss